Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Departments

The Discharge Companion Pilot Program

  1. Jennifer Bingham1,
  2. Patrick Campbell2,
  3. Sandra Leal3,
  4. Ann M. Taylor2,
  5. Kate Schussel1 and
  6. Terri Warholak2
  1. 1University of Arizona Medication Management Center, Tucson, AZ
  2. 2University of Arizona College of Pharmacy, Tucson, AZ
  3. 3SinfoníaRx, Tucson, AZ
  1. Corresponding author: Jennifer Bingham, JMBingham{at}sinfoniarx.com
Clinical Diabetes 2018 Apr; 36(2): 198-201. https://doi.org/10.2337/cd17-0106
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

IN BRIEF “Quality Improvement Success Stories” are published by the American Diabetes Association in collaboration with the American College of Physicians, Inc., and the National Diabetes Education Program. This series is intended to highlight best practices and strategies from programs and clinics that have successfully improved the quality of care for people with diabetes or related conditions. Each article in the series is reviewed and follows a standard format developed by the editors of Clinical Diabetes. The following article describes a pilot project aimed at improving overall quality of care and reducing readmissions for patients discharged from a community hospital in Arizona.

Describe your practice setting and location.

The Discharge Companion Program (DCP) pilot involved an interprofessional partnership between Tucson Medical Center, a local, nonprofit hospital, and The Medication Management Center, a university-based clinical call center. The program served patients in Tucson and the surrounding rural areas of southern Arizona.

Describe the specific quality gap addressed through the initiative.

The DCP was implemented to improve overall quality of care and reduce readmissions for patients discharged from the hospital. The Hospital Readmissions Reduction Program (HRRP), established as part of the Patient Protection and Affordable Care Act of 2010, provides financial incentives to hospitals who decrease their readmission rates for Medicare patients (1). In contrast, the Centers for Medicare & Medicaid Services (CMS) imposes penalties on hospitals with high readmission rates. The DCP addressed a need for this hospital that was directly related to these penalties.

The Medicare Payments Advisory Commission estimates that readmissions in 2017 will account for $15 billion of the projected $105 billion in total hospital-related service expenditures (2). The DCP sought to develop and implement a best-practice model to help reduce readmissions that incorporated several established quality improvement (QI) initiatives, including integration of best-practice guidelines into clinical care, reconciliation of medication lists, and an improved continuum of care for patients and health care professionals.

How did you identify this quality gap? In other words, where did you get your baseline data?

The hospital team, composed of four registered nurse chronic disease coordinators (CDCs), identified the need for a transition-of-care program such as the DCP from a root-cause analysis of key condition readmission rates, along with CMS HRRP data. The intent of this unique interprofessional team-based model was to provide additional pharmacovigilance to assist patients during the transition-of-care period after hospital discharge to decrease readmission rates and avoid penalties.

Summarize the initial data for your practice (before the improvement initiative).

Pharmacists from the University of Arizona Medical Management Center reviewed patient-reported and electronic health record (EHR) discharge medication lists and health histories to assess alignment with the American Diabetes Association’s (ADA’s) best practices for diabetes management. On implementation of the program, the DCP pharmacist discovered the following issues: four patients (3%) were prescribed a statin at an inappropriate dose intensity (guideline adherence); 16 patients (10%) had barriers to appropriate medication use (adherence); 70 patients (45%) were eligible to receive one or more immunizations (preventive care deficit); and 87 patients (56%) had at least one drug utilization concern (safety).

Additionally, the medication safety evaluation, an important component of medication reconciliation, consisted of key assessment components for 1) therapeutic duplications, 2) drug-disease interactions, 3) drug-drug interactions, 4) dose appropriateness, 5) adverse drug events, and 6) high-risk medication use in the elderly. Medication adherence was also addressed. The DCP pharmacist also ensured the appropriateness of and adherence to national consensus guideline recommendations from the ADA.

What was the timeframe from initiation of your QI initiative to its completion?

This pilot program was implemented between August 2015 and July 2016. Subsequently, based on the positive findings of the pilot program, the local hospital approved full-scale implementation of the DCP.

Describe your core QI team. Who served as project leader, and why was this person selected? Who else served on the team?

The DCP was co-coordinated by two core QI team members: the pharmacist coordinator and the nurse coordinator. These members were selected to lead the DCP given their considerable individual and collective expertise, including respective unique scopes of practice and previous experience with innovative telehealth models.

Describe the structural changes you made to your practice through this initiative.

Patients at risk for hospital readmission were identified and enrolled in the DCP pilot if they met the following criteria: 1) were ≥65 years of age and 2) had a primary discharge diagnosis of diabetes or other targeted conditions, including asthma, chronic obstructive pulmonary disorder, heart failure, myocardial infarction, pneumonia, post-coronary artery bypass graft, and renal failure. High-risk medication use in the elderly (e.g., insulin) was a consideration when patients were referred to the program; however, it was not an inclusion criterion. Initially, all qualified patients were referred to the DCP nurse by the hospital’s CDC team. Subsequently, the DCP nurse scheduled these patients for individual telephone consultations with the DCP pharmacist.

The initial patient consultation was performed via telephone by the DCP pharmacist within 1 week after discharge. Complete access to the hospital EHR was available to the DCP pharmacist for review, documentation, and preparation for the consultation. The consultation method used was dependent on where each patient was discharged to; for patients returning home, the DCP pharmacist spoke directly with patients or their caregivers (71%, n = 110), whereas for those discharged to a skilled nursing facility (SNF), the DCP pharmacist obtained the relevant medication administration record from the SNF nurse, completed the consultation based on the information provided by the SNF staff, and communicated recommendations directly to the SNF nurse (29%, n = 44).

For the direct pharmacist-patient/caregiver consultation method, teach-back education was a unique feature of this transitions-of-care model. This technique is designed to provide effective clinician-patient/caregiver communication by asking the latter to “teach back” what they have learned (3). The pharmacist assessed whether patients/caregivers understood 1) how to identify signs of a worsening condition, 2) when to seek medical attention, and 3) what lifestyle modifications to implement to prevent worsening of their condition. Additionally, the pharmacist completed a comprehensive medication safety evaluation. After the initial patient consultations, the DCP nurse coordinator contacted patients’ primary care provider, specialists, and/or dispensing pharmacy via telephone or facsimile to apprise them of the pharmacist’s recommendations and concerns and any pertinent information related to the patients’ hospitalization.

For the SNF staff consultation approach, to improve communication and avoid challenges in acquiring information by telephone (e.g., scheduling conflicts based on availability of both parties), the DCP nurse coordinator requested the medication administration record via facsimile. If this was unsuccessful, the pharmacist followed up with SNF staff within 24 hours via telephone. When the consultation was completed with SNF nursing staff, the DCP pharmacist’s notes were shared with the facility via facsimile.

For follow-up consultations, the DCP pharmacist contacted patients/caregivers or SNF staff again 3 weeks after discharge. The pharmacist revisited previously identified issues to ensure sufficient resolution and addressed any new issues regarding nonadherence, medication costs, medication changes, adverse drug events, and adherence to national consensus treatment guidelines (chronic) and Centers for Disease Control and Prevention–recommended vaccines (i.e., for influenza, pneumonia, and herpes zoster). Subsequently, the DCP nurse coordinator directly relayed any recommendations from this consultation to patients’ health care team, including specialists, primary care provider, and/or dispensing pharmacy, as needed.

Describe the most important changes you made to your process of care delivery.

Standardized, proprietary call script materials, designed for each specific discharge diagnosis based on national guidelines, were created to ensure consistency of the clinical evaluation and educational message content. The call script materials addressed three major topics: 1) how to identify signs of a worsening condition, 2) when to call for emergency assistance versus following up with a patient’s own physician, and 3) how to make lifestyle modifications to improve a patient’s overall health and well-being. Within the EHR software system, the DCP pharmacist created templates for each type of consultation (e.g., direct to patients/caregivers or via SNF staff). Additionally, the DCP nurse coordinator used a standardized call script to communicate with providers regarding the reasoning behind certain recommendations. For example, when the DCP nurse called a provider’s office, she reviewed the cardiac benefits of adding a statin cholesterol medication for patients with diabetes between 40 and 75 years of age.

Summarize your final outcome data (at the end of the improvement initiative) and how it compared to your baseline data.

A total of 482 patients from the local hospital were referred for participation in this pilot DCP during the 12-month study period. Of these, 225 patients (47%) had type 2 diabetes. Among patients with type 2 diabetes, 154 (68%) participated and received services within 30 days after discharge, including an initial telephone consultation within 1 week after discharge and follow-up telephone consultation 3 weeks after discharge. Based on the initial safety concerns identified on program implementation, respective successful interventions were made. Details are listed in Table 1.

View this table:
  • View inline
  • View popup
TABLE 1.

Medication Safety Evaluation Concerns Identified and Interventions Made by the DCP Pharmacist for Patients With Type 2 Diabetes (n = 154)

The DCP pharmacist made a total of 166 vaccine recommendations for influenza (n = 33, 20%), shingles (n = 70, 42%), and pneumonia (n = 63, 38%). Of the 63 patients who received a recommendation for a pneumococcal vaccine, 57 (90%) accepted the recommendation, whereas 6 (10%) stated that they did not want to receive the immunization. Similarly, a majority of patients accepted the immunization recommendations for influenza (n = 26, 79%) and shingles (n = 62, 89%) vaccines.

The DCP pharmacist addressed medication adherence concerns for all patients with medication-use difficulties related to patient-reported problems (n = 16), including access barriers due to cost (n = 7, 44%) and transportation (n = 1, 6%), self-reported medication use inconsistent with prescription directions (n = 4, 25%), and recommended strategies to improve medication adherence (n = 4, 25%) for patients who had difficulty remembering to take their medications. The DCP pharmacist also contacted prescribers to recommend adding statin therapy for all patients not currently following a dose regimen, based on the current ADA guidelines. For patients with type 1 or type 2 diabetes who were 40–75 years of age and had an estimated 10-year atherosclerotic cardiovascular disease (ASCVD) risk ≥7.5%, high-intensity statin therapy was recommended. Patients with a 10-year estimated ASCVD risk <7.5% were advised to receive moderate-intensity statin therapy.

Although participation in the DCP resulted in a reduction in 30-day hospital readmissions among patients with type 2 diabetes, that decrease was not statistically significant (Table 2). The trends in readmission rates are promising, and the nonsignificance of the findings may be attributed to a limited sample size and insufficient statistical power. The QI analysis showed positive patient perceptions regarding the DCP services. Furthermore, results from a survey of providers practicing in close proximity to the hospital showed that this type of interprofessional model may positively influence their future referral practices.

View this table:
  • View inline
  • View popup
TABLE 2.

Thirty-Day Readmission Rates for the DCP and Control Groups by Discharge Location

What are your next steps?

Future goals for the DCP are to expand services and collaborate with accountable care organizations and other hospital entities. Telephone consultations and remote access to the EHR enable and facilitate DCP implementation regardless of patients’ proximity to hospitals, allowing for expansion of services into underserved and rural areas. Future plans include publishing other articles reporting more in-depth results, including 30-, 60-, and 90-day post-hospitalization readmission rates, return-on-investment, and Medicare beneficiary expenditures, as well as to re-examine the data to assess all hospital readmissions (i.e., not solely readmission to the same facility).

What lessons did you learn through your QI process that you would like to share with others?

An interprofessional team collaboration with the local hospital’s nurse CDCs was crucial to the success of the pilot DCP. Additionally, the QI process provided opportunities to develop creative solutions to address issues based on receiving medication lists from the staff at the SNFs.

Duality of Interest

No potential conflicts of interest relevant to this article were reported.

Footnotes

  • J.B. and K.S. are currently affiliated with SinfoníaRx, Tucson, AZ.

  • This series is published by the American Diabetes Association in collaboration with the American College of Physicians, Inc., and the National Diabetes Education Program. The American College of Physicians and the American College of Physicians logos are trademarks or registered trademarks of American College of Physicians, Inc., in the United States and shall not be used otherwise by any third party without the prior express written consent of the American College of Physicians, Inc. Likewise, products and materials that are not developed by or in partnership with the National Diabetes Education Program are prohibited from using the National Diabetes Education Program logo.

  • © 2018 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.

References

  1. 1.↵
    1. McIlvennan CK,
    2. Eapen ZJ,
    3. Allen LA
    . Hospital readmissions reduction program. Circulation 2015;131:1796–1803
    OpenUrlFREE Full Text
  2. 2.↵
    1. Medicare Payments Advisory Commission
    . Report to the Congress: Promoting Greater Efficiency in Medicare. Washington, D.C., Medicare Payments Advisory Commission, 2007
  3. 3.↵
    1. Agency for Healthcare Research and Quality
    . The SHARE Approach: using the teach-back technique: a reference guide for health care providers. Available from http://www.ahrq.gov/professionals/education/curriculum-tools/shareddecisionmaking/tools/tool-6/index.html. Accessed 10 January 2018
PreviousNext
Back to top
Clinical Diabetes: 36 (2)

In this Issue

April 2018, 36(2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Clinical Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Discharge Companion Pilot Program
(Your Name) has forwarded a page to you from Clinical Diabetes
(Your Name) thought you would like to see this page from the Clinical Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Discharge Companion Pilot Program
Jennifer Bingham, Patrick Campbell, Sandra Leal, Ann M. Taylor, Kate Schussel, Terri Warholak
Clinical Diabetes Apr 2018, 36 (2) 198-201; DOI: 10.2337/cd17-0106

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

The Discharge Companion Pilot Program
Jennifer Bingham, Patrick Campbell, Sandra Leal, Ann M. Taylor, Kate Schussel, Terri Warholak
Clinical Diabetes Apr 2018, 36 (2) 198-201; DOI: 10.2337/cd17-0106
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Describe your practice setting and location.
    • Describe the specific quality gap addressed through the initiative.
    • How did you identify this quality gap? In other words, where did you get your baseline data?
    • Summarize the initial data for your practice (before the improvement initiative).
    • What was the timeframe from initiation of your QI initiative to its completion?
    • Describe your core QI team. Who served as project leader, and why was this person selected? Who else served on the team?
    • Describe the structural changes you made to your practice through this initiative.
    • Describe the most important changes you made to your process of care delivery.
    • Summarize your final outcome data (at the end of the improvement initiative) and how it compared to your baseline data.
    • What are your next steps?
    • What lessons did you learn through your QI process that you would like to share with others?
    • Duality of Interest
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Departments

  • Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients
  • Gvoke HypoPen: An Auto-Injector Containing an Innovative, Liquid-Stable Glucagon Formulation for Use in Severe Acute Hypoglycemia
  • Timely News and Notes for Primary Care Providers from the American Diabetes Association
Show more Departments

Quality Improvement Success Stories

  • Design and Implementation of an Electronic Tool to Measure Medication Adherence at the Point of Care
  • Strategies to Improve Annual Diabetic Foot Screening Compliance at a Family Clinic
  • Diabetic Nephropathy Screening in a Residency Clinic: Improvements Also Reveal Limits of Healthcare Effectiveness Data and Information Set (HEDIS) Metric
Show more Quality Improvement Success Stories

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Abridged Standards of Care
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.